Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
CERE

Overview Financials Analysis Smart Money

Cerevel Therapeutics Holdings, Inc.

CERE · NASDAQ

Analyze with AI

Filings2

Total reported value$0.0

Manager	Shares	Value	Change
Crystalline Management Inc.	0	$0.0	+100.0%
Eisler Capital (US) LLC	0	$0.0	+100.0%

SymbolCERE

Market Cap$8.2B

IPO Date2020-07-30

CEORonald C. Renaud Jr.,

Employees355

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

GD Culture Group Limited

GDC

$5.26

+51.59%

Peers

Roivant Sciences Ltd.

ROIV · NASDAQ

$22.41

+2.85%

Blueprint Medicines Corporation

BPMC · NASDAQ

$129.46

+0.14%

ImmunoGen, Inc.

IMGN · NASDAQ

$31.24

+0.02%

Prometheus Biosciences, Inc.

RXDX · NASDAQ

$199.92

+0.09%

IVERIC bio, Inc.

ISEE · NASDAQ

$39.95

+0.38%

Reata Pharmaceuticals, Inc.

RETA · NASDAQ

$172.36

+0.02%

Oak Street Health, Inc.

OSH · NYSE

$39.00

+0.08%

SpringWorks Therapeutics, Inc.

SWTX · NASDAQ

$46.99

+0.02%

Mirati Therapeutics, Inc.

MRTX · NASDAQ

$58.70

-0.17%

Signify Health, Inc.

SGFY · NYSE

$30.49

+0.07%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.